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Abstract
Background: Ecological momentary assessments (EMAs) and ecological momentary interventions (EMIs) represent
a novel approach for the assessment and delivery of psychological support to depressed patients in daily life.
Beyond the classical paper-and-pencil daily diaries, the more recent progresses in Information and Communication
Technologies (ICT) enabled researchers to bring all the needed processes together in only one device, i.e., response
signaling, repeated symptom collection, information storage, secure data transfer, and psychological support delivery.
Despite evidence showing the feasibility and acceptability of these techniques, EMAs are only beginning to be applied
in real clinical practice, whether the development of EMIs for clinically depressed patients is still very limited.
The objective of this systematic review is to provide the state of the art of technology-based EMAs and EMIs for major
depressive disorder (MDD), with the aim of leading the way to possible future directions for the clinical practice.
Methods: We will conduct a systematic review using the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) guidelines. Data sources will include two bibliographic databases, PubMed and Web of Science
(Web of Knowledge), supplemented by searches for unpublished or ongoing studies. Eligible studies will report data
for adult (≥ 18 years old) with a primary (both current and past) diagnosis of MDD, defined by a valid criterion
standard. We will consider studies adopting technology-based EMAs and EMIs for the investigation and/or assessment
of depression and for the delivery of a psychological intervention. We will exclude studies adopting paper-and-pencil
tools.
Discussion: The proposed systematic review will provide new insights on the advantages and benefits of adopting
technology-based EMAs and EMIs for MDD in the traditional clinical practice, taking into consideration both clinical
and technological issues. The potential of using sensors and biosensors along with machine learning for affective
modeling will also be discussed.
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Major depressive disorder (MDD) is one of the leading
causes of disease and disability in the world, affecting ap-
proximately the 4.4% of the general population [1]. Other
than impairing daily functioning [2] and quality of life [3],
convergent evidence indicates that depression is often as-
sociated with high rates of non-recovery, recurrence, and
comorbidity [4, 5]. Only in the USA, the economic burden
associated with depression was estimated at $83.1 billion
in 2000, at $173.2 billion in 2005, and at $210.5 billion in
2010 [6]. These incremental costs represent an important
public health issue, posing the clinical field with the chal-
lenge of developing new efficacious ways to assess and de-
liver psychological support to depressed people. In that
sense, Information and Communication Technologies
(ICTs) have the potential to improve traditional clinical
tools, as we will discuss in the following paragraphs.
Technology-based ecological momentary assessments for
depression
In clinical practice, symptom assessment mainly relies on
the use of retrospective questionnaires and self-reports [7].
On the one hand, a growing number of studies pointed
out the existence of multiple factors affecting mood recall
[8] and, especially in depressed patients, the presence of a
general recall bias [9, 10], like increased elaboration of
negative details, difficulties in disengaging from negative
material, and greater recall of negative rather than positive
events [11, 12]. On the other hand, symptom fluctuations
over time or even across one single day [13, 14] may lower
the accuracy and reliability of traditional assessments, thus
suggesting the importance of capturing symptom dynam-
ics with higher precision [15, 16].
In the last decade, ecological momentary assessments
(EMAs) received increasing interest and attention. Ac-
cording to Csikszentmihalyi, EMAs represent “an attempt
to provide a valid instrument to describe variations in self
reports of mental processes” and allow therefore to inves-
tigate affect, thoughts, behaviors, and symptom fluctua-
tions over time and, importantly, during the flow of daily
experience [7, 15, 17, 18]. Beyond the first studies adopt-
ing paper-and-pencil daily diaries [19], the use of elec-
tronic tools enabled researchers to bring all the needed
processes together in only one device (i.e., response signal-
ing, symptom collection, information storage, immediate
feedbacks, secure data transfer). Additionally, it is now-
adays possible to “indirectly” collect passive data by means
of device-embedded sensors or wearable biosensors and
to combine this information with self-reports [20]. Ac-
cordingly, the hierarchical sensing model proposed by
Mohr underlines the great revolution that sensors and
biosensors can bring, allowing to collect raw sensor data
that can be converted in “behavioral markers” [21].
Furthermore, another potentiality relies in the application
of machine learning algorithms. Patient-specific models
can be automatically learnt that continuously estimate pa-
tients’ affective state [22]. Alternatively, predictive models
that combine information from physiological and behav-
ioral signals to estimate the patient’s future mood, stress
level, and self-reported health (as for one or few days in
advance) can be automatically inferred from patients’ data.
Ecological momentary interventions for depression
Another challenge within the clinical field is the dissemin-
ation problem, highlighted by the great amount of people
affected by mental disorders that are not receiving adequate
treatments [23]. Despite the effectiveness of traditional
face-to-face treatments [24], individual psychotherapy is
not likely to be the solution for this large need [25].
Similarly to EMAs, ecological momentary interventions
(EMIs) are an innovative way to deliver psychological sup-
port on hand-held mobile technologies during everyday
life [26]. EMIs can be used either as stand-alone interven-
tions or in association with other treatments [26], and
with or without the involvement of a real therapist [27].
Thanks to the integration of self-reports with contextual
and physiological data derived from embedded sensors or
wearable biosensors, EMIs permit to develop
context-aware systems and more personalized interven-
tions [28]. Implemented along with short-term (hours) or
medium-term (days) data-driven predictive models of pa-
tients’ mood, stress, or affective state, the continuous
monitoring of data through sensors and biosensors could
allow both for just-in-time interventions, and for interven-
tion planning (medium-term) before the patient reaches a
critical situation, eventually involving the therapist in the
treatment loop.
Previous systematic reviews
To our knowledge, no systematic review addressing the
use of ecological momentary procedures by mean of
electronic devices has been carried out.
Aan Het Rot et al. conducted a systematic review on the
use of EMA techniques for the investigation of mood dys-
regulation [15]. Nevertheless, authors included studies
with both MDD and bipolar disorder (BD) patients, and
their main focus was on the obtained outcomes, but not
on the method itself. In the same way, Ebner-Premier and
colleagues conducted a systematic review on EMAs in the
field of mood disorders and mood dysregulation, thus in-
cluding MDD, BD, and borderline personality disorder
(BPD) patients [16] to show how EMAs can better address
research questions compared to laboratory or question-
naire studies. In both reviews, however, the adoption of
technologies was not an inclusion criterion and most of
the included studies were based on paper-and-pencil daily
diaries. Regarding interventions, no systematic review has
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been conducted on EMIs for clinically depressed patients.
To date, we could retrieve only a brief review investigating
the use of this type of interventions among all types of
psychiatric patients [29].
In conclusion, this is the first systematic review that
specifically focuses on MDD patients and that concur-
rently investigate, both from a clinical and technological
point of view, the adoption of electronic tools, sensor
and biosensors for the development of EMAs and EMIs.
Objective
To date, EMAs have been already adopted to investigate
various mental disorders [15, 30–32]. Similarly, some
EMIs have been created for schizophrenia, bipolar dis-
order and depression [30]. Nevertheless, there is still a
very huge gap between the clinical practice and the re-
search field [33]: Despite evidence supporting its feasibil-
ity and utility [16, 34, 35], the use of EMAs in clinical
settings is still very scant and the development of EMIs
for depression still very limited. On the contrary, the
clinical field could significantly benefit from them for
different reasons: (1) To overcome the dissemination
problem and develop new tools that could increase the
number of reachable people, (2) to create novel assess-
ments and interventions for MDD patients, giving much
more importance to the ecological and momentary as-
pects, and increasing the precision of clinical assess-
ments, (3) to develop more customized interventions,
mainly thanks to the potential of machine learning tech-
niques applied to data from sensors or biosensors.
The objective of this review is therefore to provide the
state of the art of technology-based EMAs and EMIs for
MDD, with the aim of leading the way to possible future
directions for the clinical practice. To realize this, our re-
view will explore the current literature on EMA and EMI
for depression, with a detailed analysis of the technological
aspects, clinical outcomes, advantages, and challenges.
The main exploratory research question of this sys-
tematic review will be the following:
 Which are the technological characteristics
(devices, sensors, biosensors) and the clinical features
and outcomes (fields of application, sampling
schemas, compliance, dropout rates, results obtained)
of the available EMAs and EMIs for depression?
In light of the obtained results, the discussion paragraph
will aim at clarifying these two explorative points:
 How and why could the clinical practice benefit
from the use of EMAs and EMIs?
 Building upon recent advances in machine learning
for affective modeling and on the available examples
of EMA and EMI studies adopting these techniques,
what are the current gaps and future developments
of EMAs and EMIs that could be tackled thanks to
the combined use of sensors and biosensors data in
addition to self-reports?
Methods
We will follow the Preferred Reporting Items for System-
atic Reviews and Meta-Analysis (PRISMA) guidelines [36].
The PRISMA-P checklist document shows this in more
detail (see Additional file 1).
Eligibility criteria
To formulate research questions and facilitate literature
search, the PICO framework has been followed [36].
Participant characteristics (P)
We will include studies involving a sample of adults
(≥ 18 years old and < 65 years old) with a primary (both




We will include studies adopting an ecological momentary
assessment by means of hand-held technologies (such as
smartphones, personal digital assistants, or hand-held
computers) for the collection of daily self-reports. The
daily self-assessments can be composed of sets of free
items or a standardized questionnaire (for instance, daily
administration of the PHQ-9). We will not include EMAs
that only rely on the collection of passive data from sen-
sors and biosensors. Indeed, we think that self-reports play
a key role within this approach, as objective observations
do not always reflect the subjective experience of them
[37]. Accordingly, a proper clinical assessment should al-
ways consider also patients’ subjective self-reports and ex-
perienced emotional states. However, we will include
studies combining self-reports with data gathered from
wearable biosensors or device-embedded sensors, and ap-
plying machine learning techniques to the acquired data,
when available.
There are no restrictions in relation to context, such
as geographical location, cultural factors, or language of
the assessment/intervention.
Ecological momentary intervention
We will include “momentary” interventions that are pro-
vided on a hand-held technology during patients’ daily
life and in specific moments of the day, i.e., according to
patients’ real-time needs. The included interventions can
be either a stand-alone or adjunctive intervention. As
for EMAs, we will also include EMIs collecting informa-
tion from wearable biosensors or device-embedded sen-
sors and applying machine learning techniques to the
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acquired data. There are no restrictions in relation to
context, such as geographical location, cultural factors,
or language of the assessment/intervention.
Comparators (C)
As we are interested in investigating all attempted devel-
opments and applications of EMI and EMA for MDD,
there are no restrictions in terms of comparators.
Outcome measures (O)
Ecological momentary assessment
As we are interested in the ecological method itself
(i.e., technology-based EMAs), we will include studies ap-
plying EMAs both for clinical assessments and research
purposes. Therefore, there are no restrictions with regard
to outcome measures. We will focus both on techno-
logical aspects (type of device, adoption of sensors or bio-
sensors, and addition to self-reports) and clinical
outcomes (investigated variables, compliance, dropout).
Ecological momentary intervention
The primary outcome measure will be clinical improve-
ment, defined as the reduction of depressive symptoms
at the end of the proposed intervention. If available, the
following secondary outcome measures will also be con-
sidered: compliance and dropout rates.
Type of studies
We will include only English papers and articles that have
an available full-text. Moreover, we will exclude the fol-
lowing types of manuscripts: conference papers, reviews,
notes, case reports, letters to the editor, editor’s notes,
extended abstracts, proceedings, patents, editorials, and
other editorial materials. There are no limitations with
respect to the design of assessment and intervention
studies to be eligible for inclusion; therefore, also
non-randomized controlled trials will be considered.
Searching and selection process
Preliminary search
A preliminary literature search in PubMed was per-
formed using key terms related to MDD and EMA/EMI.
The retrieved articles were used to identify further key-
words and build an adequate search string.
Search strategy
According to the preliminary search, we will use the com-
bination of terms listed in Table 1. Medical subject head-
ings (MeSH) or equivalent and text word terms will be
used. The search will be performed in the following elec-
tronic databases: PubMed and Web of Science (Web of
Knowledge). Information sources will not be restricted to
a specific time period. We will also search for unpublished
or ongoing researches that could be of interest for this re-
view throughout bibliographies of the retrieved studies,
and by asking to experts of the field.
Selection process
To identify and delete duplicates, database search will
be imported to a reference management software
(Endnote ×8). One author (D.C.) will further screen out-
comes manually for other duplicates.
Studies will be independently selected by three authors
(D.C., M.S., and J.F.A.). First, the three authors will
screen titles and abstracts of the retrieved studies, ex-
cluding manuscripts that are not relevant for this sys-
tematic review. The reasons for rejection will be
annotated. Subsequently, authors will retrieve the full
text-copies of the remaining articles and select those
meeting the inclusion criteria. Disagreements will be re-
solved through discussion and consensus, involving a
fourth author (C.B.) if necessary. The proportion of
agreement will be presented in the final review. The
PRISMA template will be used to reproduce the flow
chart with details on the selection process [38].
Data extraction
Three authors (C.D., J.F.A., and M.S) will create an Excel
data sheet and extract data from the selected studies.
Studies will be divided in two categories: EMA studies
and EMI studies.
Ecological momentary assessment
Data extracted from EMA studies will be as follows:
 General: authors, article title, type of publication,
year of publication;
 Study characteristics: aim of the study, main variables
of interest, type of electronic device, adoption of
sensors and biosensors, sampling methods, assessment
Table 1 Search terms to be used in the search strategy
Concept Search terms
EMA–EMI EMA, ecological momentary assessment, EMI, ecological momentary intervention, mobile health, mHealth, mobile phone, smartphone,
ecological momentary intervention, ESM, experience sampling method, ambulatory assessment, personal digital assistant, ambulatory
monitoring, real time data capture, real time monitoring, real time interventions, computer assisted diary, electronic diary
Major depressive disorder Depression, MDD, major depressive disorder, major depression, unipolar depression, emotion dysregulation, affective disorder,
mood disorder, depress*, affective symptoms, depressive symptoms
ESM experience sampling method
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duration, and type of data analysis (i.e. use of machine
learning techniques);
 Participants: number of participants, type of control
group, inclusion/exclusion criteria, dropout rates;
 Outcome measures: unit of measurement, type of
measurement, primary outcomes, compliance rates.
Ecological momentary intervention
Data extracted from EMI studies will be the following:
 General: authors, article title, type of publication,
year of publication;
 Study characteristics: aim of the study, type of
electronic device, adoption of sensors and biosensors,
sampling methods, duration and intensity of the
treatment, type of data analysis (i.e., use of machine
learning techniques);
 Participant: number of participants, control group,
inclusion/exclusion criteria, dropout rates;
 Outcome measures: unit of measurement, type of
measurement, successfulness of the intervention,
compliance, participants’ satisfaction.
Using the aforementioned key items, authors will iden-
tify and extract data independently. Subsequently, data
will be compared, and any divergence will be solved by
discussion, involving a fourth author if necessary (C.B.).
Quality assessment of the included studies
Ecological momentary assessment
The first aim of this review will be to describe the avail-
able technology-based EMAs for the assessment of
MDD and the investigation of its clinical manifestation,
taking into consideration both technological issues and
fields of application. Therefore, the assessment of meth-
odological bias is not planned for the selected EMA
studies. Authors will however analyze results taking into
consideration the methodological quality and study de-
signs of the selected studies.
Ecological momentary intervention
The primary outcome measure will be the efficacy of the
proposed intervention. As both randomized and
non-randomized controlled trials will be included, the
risk of bias will be assessed with the Downs and Black
Quality Index [39], providing both an overall score for
study quality and single scores for quality of reporting,
internal validity, power, and external validity. Two
reviewers (D.C and J.F.A.) will independently assess the
methodological quality of the included studies.
Data synthesis and result presentation
Two authors (D.C. and J.F.A.) will systematically read
the selected studies and analyze the results of each of
them. The obtained synthesis will be regularly discussed
and shared with the other authors. Results will be sum-
marized in two different tables (Table 2) and better de-
scribed in a narrative way within the result paragraph
that will be divided in two sub-sections: EMA studies
and EMI studies.
Ecological momentary assessment
We will first provide an accurate description of the psy-
chological fields of application of EMA techniques, iden-
tifying for each of them the advantages derived from this
approach. Subsequently, we will deepen the techno-
logical specifications (i.e., type of electronic devices, sen-
sors, biosensors), design features (i.e., sampling schemas,
duration, number of prompts), and clinical outcomes
(i.e., obtained results, compliance, and dropout rates) for
each included study.
Ecological momentary interventions
We will first provide a description of the currently avail-
able EMIs for depression. As for EMA studies, we will
focus both on technological (i.e., devices for intervention
delivery, sensors, and biosensors) and technical features
(i.e., sampling schemas, duration), as well as on clinical
outcomes (i.e., content of the intervention, clinical im-
provement, patients’ satisfaction/feedbacks, compliance,
and dropout rates). This process will help us to identify
the key characteristics of a successful intervention, but
also highlight possible pitfalls that could be improved.
As systematic review is an iterative process, this result
schema could be redefined as the work progresses.
Discussion
Depression represents an important public health con-
cern, and the development and implementation of new
tools is becoming a clinical priority. In that sense, new
technologies could lead to the development of innova-
tive assessments with greater ecological validity and
higher precision, and to the delivery of more customized
interventions to a greater number of people in need.
Nevertheless, there still exists a huge gap between the
clinical practice and the research field, and the
Table 2 Key items for result tables
Key items
EMA Author(s), Sample(s), Variable(s), Device(s), Sensor(s), Duration, Prompt(s) per day, Sampling Schema, Primary Outcome(s);
EMI Author(s), Name of the intervention, Sample(s), Content of the Intervention, Duration, Sensor(s), Primary Outcome(s).
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development and use of EMAs and EMIs is mainly con-
fined to laboratory settings.
This systematic review will provide a detailed overview
of the state of the art of technology-based EMAs and
EMIs for clinically depressed patients. The analysis of
both technological, design and clinical aspects will enable
us to better identify the advantages and disadvantages of
this approach and clarify the research questions opening
this review. On the one hand, we will try to identify which
clinical fields could actually benefit from the use of
technology-based EMAs and EMIs; on the other hand, we
will deepen how these tools could be improved. More spe-
cifically, we will discuss how the addition of passive data
derived from embedded-sensors and wearable biosensors
to the traditional self-reports could further foster the po-
tentialities of this approach, and how recent advancements
machine learning techniques could fill the current techno-
logical gap in EMA and EMI frameworks.
Additional file
Additional file 1: PRISMA-P checklist. (DOCX 36 kb)
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